Attrition in treatment-resistant depression: predictors and clinical impact

Paolo Olgiati, Alessandro Serretti*, Daniel Souery, Siegfried Kasper, Christoph Kraus, Stuart Montgomery, Joseph Zohar, Julien Mendlewicz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

The aim of this study was to investigate attrition (dropout) during a second antidepressant trial in treatment-resistant depression. Three hundred forty-two outpatients with major depressive disorder and lack of response to a prior antidepressant were treated with venlafaxine for 6 weeks. Sociodemographic and clinical characteristics were compared between the attrition and non-attrition groups. Attrition was reported in 65 patients (19%), of whom 30 patients (46%) dropped out within week 4. The characteristics of dropout patients included a longer duration of depressive episode (P = 0.011) and lower antidepressant doses (P < 0.0001) as a consequence of a faster decrease (week 2) in depressive symptoms (P = 0.028). However, by controlling for early improvement, dropout subjects were associated with a smaller probability of antidepressant response (odds ratio = 0.16▪.83). A decrease of at least 30% in Montgomery Asberg Depression Rating Scale on day 14 predicted subsequent dropout with high specificity (81.9%▪1.0%) but lower sensitivity (19.6%▪2.8%) for clinical use. Patients who have been depressed for a longer period and show an initial improvement of symptoms after changing their antidepressant may be at increased risk for drop out. Further studies are necessary to ascertain the usefulness of these characteristics for predicting attrition.

Original languageEnglish
Pages (from-to)161-169
Number of pages9
JournalInternational Clinical Psychopharmacology
Volume34
Issue number4
DOIs
StatePublished - 1 Jul 2019
Externally publishedYes

Keywords

  • antidepressant
  • attrition
  • improvement
  • predictor
  • treatment-resistant depression

Fingerprint

Dive into the research topics of 'Attrition in treatment-resistant depression: predictors and clinical impact'. Together they form a unique fingerprint.

Cite this